Neural “signature” may reflect how we respond to feelings of social isolation
Large multi-site study accurately predicts damage to grey matter by disease
An international study has found a link between the brain’s network connections and grey matter atrophy caused by certain types of epilepsy, a major step forward in our understanding of the disease.
Doctor has dedicated his life to improve diagnosis and treatment of neurological diseases and disorders
The Neuro’s director, Dr. Guy Rouleau, is being recognized with Canada’s highest civilian honour, the Order of Canada, for his outstanding contributions as a clinician-scientist and as a leader in health care.
Brain Canada program supports paradigm-shifting neuroscience that improves the lives of Canadians
Four researchers at The Neuro — Boris Bernhardt, Yasser Iturria-Medina, Jean-Francois Poulin, and Jo Anne Stratton — have received grants to support their work in the early-career stage, after being chosen from 150 talented applicants.
Work will tell us how loneliness interacts with brain structure and function in normal aging and pre-symptomatic Alzheimer’s disease
Study identifies rapidly dividing cancer stem cells that can respond to new therapies
Brain cancers have long been thought of as being resistant to treatments because of the presence of multiple types of cancer cells within each tumor. A new study uncovers a cancer cell hierarchy that originates from a single cancer cell type, which can be targeted to slow cancer growth.
July 4, 2020
Updated Directives Research Ramp-up Phase 3
As of July 8, 2020, all researchers who cannot perform their tasks remotely will be allowed to return to work, in compliance with all safety protocols.
As a consequence, the restriction of a maximum of 75% of staff whose tasks require presence at work is lifted.
updated October 29, 2020
On this page: RESEARCH WITH HUMAN SUBJECTS (Updated October 29) | PROCESS FOR RESUMING RESEARCH WITH HUMAN SUBJECTS | APPLY TO RESTART YOUR RESEARCH
RESEARCH WITH HUMAN SUBJECTSUpdated October 29
Current on-site research with human subjects may continue with people in the following four categories:
IMPORTANT Within the above three groups, subjects 70 years of age and older already coming into The Neuro for these purposes can still participate in research activities. New subjects 70 years and older cannot be recruited for studies until further notice.Patients enrolled in clinical trials. Patients who are scheduled to come in for regular care or treatment. Patients who are scheduled to be seen by physicians on a regular basis. Patients already enrolled in on-going longitudinal studies, with the exception of people over 70 years of age. All in-person studies with healthy control subjects of all ages are CANCELLED until further notice.
These directives will be reassessed on November 23 or as the situation evolves.
C. L. de Carvalho-Heineken Prize recognizes his seminal work in the cognition of music
Cognitive neuroscientist Robert Zatorre has been awarded the C.L. de Carvalho-Heineken Prize in Cognitive Sciences.
REQUEST ACCESS FOR EXTERNAL VENDORS Deliveries, Servicing of Equipment and other Services & Maintenance visits
Please fill out your request using the following link:https://app.smartsheet.com/b/form/fdfa5c541277492da5d96310e124eb37
Award recognizes his collaborative work in neuroscience and neuroinformatics
Neuroscientist Alan Evans has been awarded the Killam Prize, one of Canada’s highest honours, for his numerous contributions to the understanding of the human brain.
Evans is an internationally recognized researcher at The Neuro (Montreal Neurological Institute-Hospital), James McGill Professor in Neurology and Neurosurgery and the Victor Dahdaleh Chair in Neurosciences.
Restart of research activities at The Neuro will follow the McGill University on-campus research phase-in directives and the guidelines on preventing spread of COVID-19.
As The Neuro moves into a transition phase, which includes the gradual resumption of research activities starting on Monday May 25th, please note that use of elevators is now restricted (please see table below).Elevator A (Rockefeller) is accessible for patients, hospital and research staff.
· Patients have priority access.
I hope you have been keeping well.
As you know, McGill sent out a memo over the weekend regarding the gradual research ramp-up on campus.
We are presently establishing guidelines specific to the ramp-up of the research operations at The Neuro, in compliance with both McGill and MUHC protocols (ex: entry points and triage, movement within the complex, health and safety considerations, issues related to human resources, etc.).
Neuro staff and trainees are reminded NOT to enter or exit the building via any other doors.* The only exception is in case of emergency evacuation.
Please respect the requests of security and frontline staff at the main entrance. Tensions can sometimes run high in crisis situations and we ask that everyone be patient and courteous.